These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 23872479)

  • 1. TRAF3IP2 mediates interleukin-18-induced cardiac fibroblast migration and differentiation.
    Valente AJ; Sakamuri SS; Siddesha JM; Yoshida T; Gardner JD; Prabhu R; Siebenlist U; Chandrasekar B
    Cell Signal; 2013 Nov; 25(11):2176-84. PubMed ID: 23872479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-18 enhances IL-18R/Nox1 binding, and mediates TRAF3IP2-dependent smooth muscle cell migration. Inhibition by simvastatin.
    Valente AJ; Yoshida T; Izadpanah R; Delafontaine P; Siebenlist U; Chandrasekar B
    Cell Signal; 2013 Jun; 25(6):1447-56. PubMed ID: 23541442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Nox1/4 Dual Inhibitor GKT137831 or Nox4 Knockdown Inhibits Angiotensin-II-Induced Adult Mouse Cardiac Fibroblast Proliferation and Migration. AT1 Physically Associates With Nox4.
    Somanna NK; Valente AJ; Krenz M; Fay WP; Delafontaine P; Chandrasekar B
    J Cell Physiol; 2016 May; 231(5):1130-41. PubMed ID: 26445208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CIKS (Act1 or TRAF3IP2) mediates high glucose-induced endothelial dysfunction.
    Venkatesan B; Valente AJ; Das NA; Carpenter AJ; Yoshida T; Delafontaine JL; Siebenlist U; Chandrasekar B
    Cell Signal; 2013 Jan; 25(1):359-71. PubMed ID: 23085260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRAF3IP2 mediates TWEAK/TWEAKR-induced pro-fibrotic responses in cultured cardiac fibroblasts and the heart.
    Das NA; Carpenter AJ; Yoshida T; Kumar SA; Gautam S; Mostany R; Izadpanah R; Kumar A; Mummidi S; Siebenlist U; Chandrasekar B
    J Mol Cell Cardiol; 2018 Aug; 121():107-123. PubMed ID: 29981796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin II stimulates cardiac fibroblast migration via the differential regulation of matrixins and RECK.
    Siddesha JM; Valente AJ; Sakamuri SS; Yoshida T; Gardner JD; Somanna N; Takahashi C; Noda M; Chandrasekar B
    J Mol Cell Cardiol; 2013 Dec; 65():9-18. PubMed ID: 24095877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CIKS (Act1 or TRAF3IP2) mediates Angiotensin-II-induced Interleukin-18 expression, and Nox2-dependent cardiomyocyte hypertrophy.
    Valente AJ; Clark RA; Siddesha JM; Siebenlist U; Chandrasekar B
    J Mol Cell Cardiol; 2012 Jul; 53(1):113-24. PubMed ID: 22575763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac-restricted Overexpression of TRAF3 Interacting Protein 2 (TRAF3IP2) Results in Spontaneous Development of Myocardial Hypertrophy, Fibrosis, and Dysfunction.
    Yariswamy M; Yoshida T; Valente AJ; Kandikattu HK; Sakamuri SS; Siddesha JM; Sukhanov S; Saifudeen Z; Ma L; Siebenlist U; Gardner JD; Chandrasekar B
    J Biol Chem; 2016 Sep; 291(37):19425-36. PubMed ID: 27466370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TRAF3IP2 mediates aldosterone/salt-induced cardiac hypertrophy and fibrosis.
    Sakamuri SS; Valente AJ; Siddesha JM; Delafontaine P; Siebenlist U; Gardner JD; Bysani C
    Mol Cell Endocrinol; 2016 Jul; 429():84-92. PubMed ID: 27040306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular basis and functional significance of Angiotensin II-induced increase in Discoidin Domain Receptor 2 gene expression in cardiac fibroblasts.
    George M; Vijayakumar A; Dhanesh SB; James J; Shivakumar K
    J Mol Cell Cardiol; 2016 Jan; 90():59-69. PubMed ID: 26674152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dipeptidyl peptidase-4 (DPP-4) inhibition with linagliptin reduces western diet-induced myocardial TRAF3IP2 expression, inflammation and fibrosis in female mice.
    Aroor AR; Habibi J; Kandikattu HK; Garro-Kacher M; Barron B; Chen D; Hayden MR; Whaley-Connell A; Bender SB; Klein T; Padilla J; Sowers JR; Chandrasekar B; DeMarco VG
    Cardiovasc Diabetol; 2017 May; 16(1):61. PubMed ID: 28476142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aldosterone-induced cardiomyocyte growth, and fibroblast migration and proliferation are mediated by TRAF3IP2.
    Somanna NK; Yariswamy M; Garagliano JM; Siebenlist U; Mummidi S; Valente AJ; Chandrasekar B
    Cell Signal; 2015 Oct; 27(10):1928-38. PubMed ID: 26148936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-17 stimulates MMP-1 expression in primary human cardiac fibroblasts via p38 MAPK- and ERK1/2-dependent C/EBP-beta , NF-kappaB, and AP-1 activation.
    Cortez DM; Feldman MD; Mummidi S; Valente AJ; Steffensen B; Vincenti M; Barnes JL; Chandrasekar B
    Am J Physiol Heart Circ Physiol; 2007 Dec; 293(6):H3356-65. PubMed ID: 17921324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acetylsalicylic acid inhibits IL-18-induced cardiac fibroblast migration through the induction of RECK.
    Siddesha JM; Valente AJ; Sakamuri SS; Gardner JD; Delafontaine P; Noda M; Chandrasekar B
    J Cell Physiol; 2014 Jul; 229(7):845-55. PubMed ID: 24265116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metformin inhibits aldosterone-induced cardiac fibroblast activation, migration and proliferation in vitro, and reverses aldosterone+salt-induced cardiac fibrosis in vivo.
    Mummidi S; Das NA; Carpenter AJ; Kandikattu H; Krenz M; Siebenlist U; Valente AJ; Chandrasekar B
    J Mol Cell Cardiol; 2016 Sep; 98():95-102. PubMed ID: 27423273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting TRAF3IP2 by Genetic and Interventional Approaches Inhibits Ischemia/Reperfusion-induced Myocardial Injury and Adverse Remodeling.
    Erikson JM; Valente AJ; Mummidi S; Kandikattu HK; DeMarco VG; Bender SB; Fay WP; Siebenlist U; Chandrasekar B
    J Biol Chem; 2017 Feb; 292(6):2345-2358. PubMed ID: 28053087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RECK suppresses interleukin-17/TRAF3IP2-mediated MMP-13 activation and human aortic smooth muscle cell migration and proliferation.
    Mummidi S; Das NA; Carpenter AJ; Yoshida T; Yariswamy M; Mostany R; Izadpanah R; Higashi Y; Sukhanov S; Noda M; Siebenlist U; Rector RS; Chandrasekar B
    J Cell Physiol; 2019 Dec; 234(12):22242-22259. PubMed ID: 31074012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of Cannabinoid Receptor Type II by AM1241 Ameliorates Myocardial Fibrosis via Nrf2-Mediated Inhibition of TGF-β1/Smad3 Pathway in Myocardial Infarction Mice.
    Li X; Han D; Tian Z; Gao B; Fan M; Li C; Li X; Wang Y; Ma S; Cao F
    Cell Physiol Biochem; 2016; 39(4):1521-36. PubMed ID: 27614871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin II-mediated oxidative stress and procollagen-1 expression in cardiac fibroblasts: blockade by pravastatin and pioglitazone.
    Chen J; Mehta JL
    Am J Physiol Heart Circ Physiol; 2006 Oct; 291(4):H1738-45. PubMed ID: 16714359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin II enhances AT1-Nox1 binding and stimulates arterial smooth muscle cell migration and proliferation through AT1, Nox1, and interleukin-18.
    Valente AJ; Yoshida T; Murthy SN; Sakamuri SS; Katsuyama M; Clark RA; Delafontaine P; Chandrasekar B
    Am J Physiol Heart Circ Physiol; 2012 Aug; 303(3):H282-96. PubMed ID: 22636674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.